Information  X 
Enter a valid email address

Morgan Stanley & Co. (19PK)

  Print      Mail a friend

Monday 23 November, 2015

Morgan Stanley & Co.

Rule 38.5 - Pfizer INC

RNS Number : 6074G
Morgan Stanley & Co. Int'l plc
23 November 2015
 



 

 FORM 38.5(a)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

 

 

1.             KEY INFORMATION

 Name of exempt market-maker

   Morgan Stanley & Co. International plc

 Company dealt in

   PFIZER INC

 Class of relevant security to which the dealings being disclosed relate (Note 1)

  US$0.05 COMMON STOCK

 Date of dealing

   20 NOVEMBER 2015

 

 

2.             DEALINGS (Note 2)

 

(a)           Purchases and sales

 Total number of relevant secuities accquired

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

  360

 30.2000 EUR

 30.0950 EUR

  43,089

 32.5500 USD

 32.1000 USD

 

 Total number of relevant secuities disposed

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

  290

 30.3000 EUR

 30.2000 EUR

  43,089

 32.5500 USD

 32.1000 USD

 

 

(b)           Derivatives transactions (other than options transactions)

 

 Product name, e.g. CFD

 Nature of transaction

                (Note 4)

 Number of relevant securities

                (Note 5)

 Price per unit

 CFD

 LONG

 40

 30.3000 EUR

 CFD

 SHORT

 110

 30.0950 EUR

 CFD

 LONG

 753

 32.1800 USD

 CFD

 LONG

 829

 32.4254 USD

 CFD

 SHORT

 100

 32.1550 USD

 CFD

 SHORT

 200

 32.1550 USD

 CFD

 SHORT

 200

 32.1550 USD

 CFD

 SHORT

 1,215

 32.1800 USD

 CFD

 SHORT

 4,155

 32.1800 USD

 CFD

 SHORT

 785

 32.1800 USD

 CFD

 SHORT

 479,233

 32.4448 USD

 CFD

 SHORT

 2,781

 32.5500 USD

 

 

(c)            Options transactions in respect of existing relevant securities

 

i)           Writing, selling, purchasing or varying

 

 Product name, eg call option

 Writing, selling, purchasing, varying etc

 Number of securities to which the option relates (Note 5)

 Exercise Price

 Type, e.g American, European etc

 Expiry Date

 Option money paid/received per unit (Note 3)

 CALL

 SALE

 4,350,000

 1.0000

 E

 30/11/2018

 1.1000 SEK

 CALL

 PURCHASE

 501,730

 1.0000

 E

 30/11/2018

 0.9999 USD

 

(ii) Exercising

 

 Product name, eg call option

 Number of securities

 Exercise price per unit (Note 3)

 N/A

 N/A

 N/A 

 

 

3. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 Date of disclosure

 23 NOVEMBER 2015

 Contact Name

Craig Horsley

 Telephone Number

+44(141) 245 7736

 Name of offeree/offeror with which connected

ALLERGAN PLC

Nature of connection (Note 6)

Advisory

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEPKNDPKBDDPDB

a d v e r t i s e m e n t